Preview

Russian Journal for Personalized Medicine

Advanced search

Sex differences in some functional parameters in rats at the initial stage of diabetes development

https://doi.org/10.18705/2782-3806-2025-5-4-364-374

Abstract

Relevance. Diabetes mellitus (DM) is characterized by a long, asymptomatic course, when heart already occur and disturbances of metabolism, but do not manifest clinically. To understand the need for therapeutic prevention of possible complications of DM, it is important to study the sex-specific features of the functional state of the heart and metabolism at the DM development. Objective. To study the sex-specific features of electrophysiological parameters of the heart and general metabolism indicators in male and female rats at the initial stages of DM 2. Materials and methods. DM was induced in 20 rats of both sexes by a single intraperitoneal administration of alloxan at a dose of 150 mg/kg. Electrocardiogram (ECG) was recorded noninvasively: RR, PQ, QRS, QT intervals, P, R, T wave amplitude, and RН heart rate were assessed. Metabolic parameters were determined: volumes of consumed O2 and exhaled CO2, heat production intensity (HPI, kcal/kg/h). All parameters were assessed before administration, on days 3 and 6 after alloxan administration. Results. On day 3 after alloxan administration, blood glucose levels increased relative to baseline: 5.9 times in males and 7.0 times in females. On day 6, the glucose level was higher than the initial level: 3.2 times in males and 1.5 times in females; moreover, in males it was 2.5 times higher than in females. Pathological ECG changes — rhythm irregularity, decreased amplitude of P and T waves below the isoline, widening of the QRS complex were detected in both males and females on days 3 and 6 of diabetes. Metabolic parameters decreased only in males at all observation periods. Conclusion. In the first week of diabetes, rats showed systolic and diastolic dysfunction of the heart, decreased metabolic intensity. The most pronounced changes were noted in males, which was due to a higher glycemia than in females. 

About the Authors

E. A. Sheiko
National Medical Research Centre For Oncology
Russian Federation

Sheiko Elena A., PhD of Biological Sciences, Professor of the Russian Academy of Engineering, Junior Researcher, Laboratory for Studying the Pathogenesis of Malignant Tumors

14 liniya str., 63, Rostov-on-Don, 344037



E. I. Surikova
National Medical Research Centre For Oncology
Russian Federation

Surikova Ekaterina I., PhD of Biological Sciences, Senior Researcher, Laboratory for Studying the Pathogenesis of Malignant Tumors

Rostov-on-Don



I. V. Kaplyeva
National Medical Research Centre For Oncology
Russian Federation

Kaplyeva Irina V., MD, PhD, DSc, Head of the Laboratory for Studying the Pathogenesis of Malignant Tumors

Rostov-on-Don



L. K. Trepitaki
National Medical Research Centre For Oncology
Russian Federation

Trepitaki Lidiya K., PhD of Biological Sciences, Researcher, Laboratory for Studying the Pathogenesis of Malignant Tumors

Rostov-on-Don



P. S. Kachesova
National Medical Research Centre For Oncology
Russian Federation

Kachesova Polina S., Researcher, Laboratory for
Studying the Pathogenesis of Malignant Tumors

Rostov-on-Don



N. D. Ushakova
National Medical Research Centre For Oncology
Russian Federation

Ushakova Natalia D., MD, PhD, DSc, Professor, Anesthesiologist

Rostov-on-Don



References

1. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https://doi.org/10.1016/j.diabres.2021.109119

2. The top 10 causes of death [Internet]. WHO; 2020 [cited 06 June 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

3. Thomas MC. The clustering of cardiovascular, renal, adipo-metabolic eye and liver disease with type 2 diabetes. Metabolism. 2022;128:154961. https://doi.org/10.1016/j.metabol.2021.154961

4. Gorokhovskaya GN, Yun VL, Martynov AI, et al. Relationship of type 2 diabetes mellitus and cardiovascular pathology: significance of glycemic control on the way to solving the problem. Meditsinskiy sovet = Medical Council. 2020;(4):22–28. (In Russ.) https://doi.org/10.21518/2079-701X-2020-4-22-28

5. Zhao X, Liu S, Wang X, et al. Diabetic cardiomyopathy: clinical phenotype and practice. Front Endocrinol. 2022;13:1032268. https://doi.org/.3389/fendo.2022.1032268

6. Madhariya R, Dixena B, Ram A, et al. Experimental animal models: tools to investigate antidiabetic activity. Curr Pharm Des. 2023;29(2):79–94. https://doi.org/10.2174/1381612829666221220115649

7. Kong SY, Cho MK. Effects of continous glucose monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Healthcare. 2024;12(5):571. https://doi.org/10.3390/healthcare12050571

8. Rubin JB, Lagas JS, Broestl L, et al. Sex differences in cancer mechanisms. Biol Sex Differ. 2020;11(1):17. https://doi.org/10.1186/s13293-020-00291-x

9. Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453–461. https://doi.org/10.1007/s00125-019-05040-3

10. Wang Z, Yang Y, Xiang X, et al. Estimation of the normal range of blood glucose in rats. Wei Sheng Yan Jiu. 2010;39(2):133–137.

11. Youssef ME, El-Azab MF, Abdel-Dayem MA, et al. Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats. Environ Sci Pollut Res Int. 2022;29(17):25723–25732. https://doi.org/10.1007/s11356-021-17831-6

12. Konopelski P, Ufnal M. Electrocardiography in rats: a comparison to human. Physiol Res. 2016;65(5):717– 725. https://doi.org/10.33549/physiolres.933270

13. Privalova I, Shevelev O, Hodorovich N, et al. Electrocardiography in rats in experimental studies (review of the literature). Genetics and breeding of animals. 2019;2:108–114. (In Russ.) https://doi.org/10.3143/2410-2733-2019-2-108-120

14. Hong SI, Kim JS, Kim YJ, Kim WY. Dynamic changes in arterial blood gas during cardiopulmonary resuscitation in out-of-hospital cardiac arrest. Sci Rep. 2021;11(1):23165. https://doi.org/10.1038/s41598-021-02764-4

15. Payne SJ, Mohammad J, Tisdall MM, Tachtsidis I. Effects of arterial blood gas levels on cerebral blood flow and oxygen transport. Biomed Opt Express. 2011;2(4):966– 979. https://doi.org/10.1364/BOE.2.000979

16. Riaz A, Asghar S, Shahid S, et al. Prevalence of metabolic syndrome and its risk factors influence on microvascular complications in patients with type 1 and type 2 diabetes mellitus. Cureus. 2024;16(3):e55478. https://doi.org/10.7759/cureus.55478

17. Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):1501–1525. https://doi.org/10.1161/CIRCRESAHA.120.315913

18. Huo X, Zhang J, Guo X, et al. Gender difference in the association of early- vs. late-onset type 2 dia- betes with non-fatal microvascular disease in china: a cross-sectional study. Front Endocrinol. 2018;9:15. https://doi.org/10.3389/fendo.2018.00015

19. Zhang Y, Wang Y, Yanni J, et al. Electrical conduction system remodeling in streptozotocin-induced diabetes mellitus rat heart. Front Physiol. 2019;10:826. https://doi.org/10.3389/fphys.2019.00826

20. Tavares JG, Vasques ER, Arida RM, et al. Epilepsy-induced electrocardiographic alterations following cardiac ischemia and reperfusion in rats. Braz J Med Biol Res. 2015;48(2):140–145.

21. Sokolova IB. Impact of metabolic disturbances and streptozotocin-induced diabetes on cerebral circulation in rats fed a high-fat diet. Russian Journal of Physiology. 2022;108(6):762–770. (In Russ.) https://doi.org/10.31857/S0869813922060085

22. Mozheyko L.A. Experimental models of diabetes mellitus. Part 1. Alloxan diabetes. (Review). Zhurnal Grodnenskogo Gosudarstvennogo Universiteta. 2013;3:26-29.


Review

For citations:


Sheiko E.A., Surikova E.I., Kaplyeva I.V., Trepitaki L.K., Kachesova P.S., Ushakova N.D. Sex differences in some functional parameters in rats at the initial stage of diabetes development. Russian Journal for Personalized Medicine. 2025;5(4):364-374. (In Russ.) https://doi.org/10.18705/2782-3806-2025-5-4-364-374

Views: 68


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2782-3806 (Print)
ISSN 2782-3814 (Online)